Plain-English translation of NCT06076005 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This is an observational study — meaning researchers are not testing a new drug or treatment, but rather collecting information from people newly diagnosed with advanced lung cancer. The study will gather tissue samples, imaging results, and medical details from 1,000 patients at two major Italian cancer centers to build a comprehensive picture of how advanced lung cancer looks and behaves at the time of diagnosis.
Right now, doctors don't have a clear, systematic understanding of the different types of advanced lung cancer and how they vary from patient to patient in Italy. By collecting this information from a large group of newly diagnosed patients, researchers hope to better understand disease patterns and potentially improve how doctors diagnose and treat lung cancer in the future.
You likely qualify if…
You likely don't qualify if…
If you join, you will have a tissue biopsy (a small sample of lung tissue taken for testing) as part of your normal diagnostic workup — this is something your doctor would likely recommend anyway. Researchers will also collect your medical history, imaging results, and information about your disease characteristics. The study does not involve taking any new medications or making additional visits beyond your standard cancer care.
AI-generated summary from trial data · Aug 1, 2026 · Not medical advice
Italy